INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773H901. A total of 4 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60 | -11.8% | 156,500 | +1.4% | 0.00% | – |
| Q2 2023 | $68 | -45.6% | 154,400 | +0.7% | 0.00% | – |
| Q1 2023 | $125 | -44.4% | 153,400 | +6.2% | 0.00% | – |
| Q4 2022 | $225 | -99.9% | 144,400 | +19.0% | 0.00% | – |
| Q3 2022 | $209,000 | +38.4% | 121,300 | +38.2% | 0.00% | – |
| Q2 2022 | $151,000 | -49.0% | 87,800 | +6.4% | 0.00% | – |
| Q1 2022 | $296,000 | -80.9% | 82,500 | -73.5% | 0.00% | -100.0% |
| Q4 2021 | $1,551,000 | -47.9% | 310,900 | -1.1% | 0.00% | -33.3% |
| Q3 2021 | $2,975,000 | +2.0% | 314,500 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $2,918,000 | – | 314,800 | +9277.4% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 3,357 | -23.5% | 0.00% | -100.0% |
| Q4 2020 | $3,882,000 | -68.8% | 4,387 | -59.1% | 0.01% | -70.6% |
| Q3 2020 | $12,457,000 | -34.8% | 10,739 | +51.4% | 0.02% | -43.3% |
| Q2 2020 | $19,112,000 | +445.1% | 7,092 | +50.5% | 0.03% | +400.0% |
| Q1 2020 | $3,506,000 | +9375.7% | 4,713 | +4034.2% | 0.01% | – |
| Q4 2019 | $37,000 | +825.0% | 114 | +470.0% | 0.00% | – |
| Q3 2019 | $4,000 | -78.9% | 20 | -70.1% | 0.00% | – |
| Q2 2019 | $19,000 | +26.7% | 67 | +59.5% | 0.00% | – |
| Q1 2019 | $15,000 | -85.3% | 42 | -83.7% | 0.00% | – |
| Q4 2018 | $102,000 | +59.4% | 257 | +121.6% | 0.00% | – |
| Q3 2018 | $64,000 | +204.8% | 116 | +114.8% | 0.00% | – |
| Q2 2018 | $21,000 | +600.0% | 54 | +80.0% | 0.00% | – |
| Q1 2018 | $3,000 | -50.0% | 30 | -42.3% | 0.00% | – |
| Q4 2017 | $6,000 | -72.7% | 52 | -83.6% | 0.00% | -100.0% |
| Q3 2017 | $22,000 | -18.5% | 317 | -25.4% | 0.00% | 0.0% |
| Q2 2017 | $27,000 | +2600.0% | 425 | +645.6% | 0.00% | – |
| Q1 2017 | $1,000 | -91.7% | 57 | -87.7% | 0.00% | -100.0% |
| Q4 2016 | $12,000 | -88.6% | 464 | -36.9% | 0.00% | -85.7% |
| Q3 2016 | $105,000 | -26.6% | 735 | -25.0% | 0.01% | -30.0% |
| Q2 2016 | $143,000 | +52.1% | 980 | +115.9% | 0.01% | +42.9% |
| Q1 2016 | $94,000 | +623.1% | 454 | +61.0% | 0.01% | +600.0% |
| Q4 2015 | $13,000 | -13.3% | 282 | +75.2% | 0.00% | 0.0% |
| Q3 2015 | $15,000 | +25.0% | 161 | -9.6% | 0.00% | 0.0% |
| Q2 2015 | $12,000 | -36.8% | 178 | +125.3% | 0.00% | -50.0% |
| Q1 2015 | $19,000 | -9.5% | 79 | -20.2% | 0.00% | -33.3% |
| Q4 2014 | $21,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 348,400 | $3,219,000 | 0.04% |
| SIMPLEX TRADING, LLC | 980 | $143,000 | 0.01% |
| Citadel Advisors | 33,600 | $310,000 | 0.00% |